PT1070503E - Composicoes compreendendo heparina de peso molecular muito reduzido - Google Patents

Composicoes compreendendo heparina de peso molecular muito reduzido

Info

Publication number
PT1070503E
PT1070503E PT99500184T PT99500184T PT1070503E PT 1070503 E PT1070503 E PT 1070503E PT 99500184 T PT99500184 T PT 99500184T PT 99500184 T PT99500184 T PT 99500184T PT 1070503 E PT1070503 E PT 1070503E
Authority
PT
Portugal
Prior art keywords
molecular weight
weight heparin
reduced molecular
compositions
compositions understanding
Prior art date
Application number
PT99500184T
Other languages
English (en)
Inventor
Mardiguian Jean
Original Assignee
Rovi Lab Farmaceut Sa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Rovi Lab Farmaceut Sa filed Critical Rovi Lab Farmaceut Sa
Publication of PT1070503E publication Critical patent/PT1070503E/pt

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/715—Polysaccharides, i.e. having more than five saccharide radicals attached to each other by glycosidic linkages; Derivatives thereof, e.g. ethers, esters
    • A61K31/726—Glycosaminoglycans, i.e. mucopolysaccharides
    • A61K31/727—Heparin; Heparan
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/14—Vasoprotectives; Antihaemorrhoidals; Drugs for varicose therapy; Capillary stabilisers

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Dermatology (AREA)
  • Cardiology (AREA)
  • Molecular Biology (AREA)
  • Epidemiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Vascular Medicine (AREA)
  • Diabetes (AREA)
  • Hematology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Polysaccharides And Polysaccharide Derivatives (AREA)
PT99500184T 1999-07-23 1999-10-13 Composicoes compreendendo heparina de peso molecular muito reduzido PT1070503E (pt)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
ES009901671A ES2161615B1 (es) 1999-07-23 1999-07-23 Composiciones de heparinas de muy bajo peso molecular.

Publications (1)

Publication Number Publication Date
PT1070503E true PT1070503E (pt) 2005-10-31

Family

ID=8309360

Family Applications (1)

Application Number Title Priority Date Filing Date
PT99500184T PT1070503E (pt) 1999-07-23 1999-10-13 Composicoes compreendendo heparina de peso molecular muito reduzido

Country Status (8)

Country Link
US (1) US6384021B1 (pt)
EP (1) EP1070503B8 (pt)
AT (1) ATE309693T1 (pt)
BR (1) BR9905820A (pt)
DE (1) DE69925821T2 (pt)
DK (1) DK1070503T3 (pt)
ES (2) ES2161615B1 (pt)
PT (1) PT1070503E (pt)

Families Citing this family (25)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2811992B1 (fr) 2000-07-21 2003-07-04 Aventis Pharma Sa Melanges de polysaccharides derives d'heparine, leur preparation et les compositions pharmaceutiques les contenant
US6969705B2 (en) * 2000-07-21 2005-11-29 Aventis Pharma S.A. Compositions of polysaccharides derived from heparin, their preparation and pharmaceutical compositions containing them
EP2284535A1 (en) 2002-03-11 2011-02-16 Momenta Pharmaceuticals, Inc. Low molecular weight heparins
AR041555A1 (es) 2002-10-10 2005-05-18 Aventis Pharma Sa Mezclas de polisacaridos derivados de heparina, su preparacion y las composiciones farmaceuticas que las contienen
FR2845686B1 (fr) * 2002-10-10 2013-08-30 Aventis Pharma Sa Melanges de polysaccharides derives d'heparine, leur preparation et les compositions pharmaceutiques les contenant
US20040171819A1 (en) * 2002-10-10 2004-09-02 Aventis Pharma S.A. Mixtures of polysaccharides derived from heparin, their preparation and pharmaceutical compositions containing them
US7956046B2 (en) 2003-07-24 2011-06-07 Aventis Pharma S.A. Oligosaccharide mixtures derived from heparin, preparation thereof and pharmaceutical compositions containing them
FR2857971B1 (fr) * 2003-07-24 2005-08-26 Aventis Pharma Sa Melanges d'oligosaccharides derives d'heparine, leur preparation et les compositions pharmaceutiques les contenant
GB0327723D0 (en) * 2003-09-15 2003-12-31 Vectura Ltd Pharmaceutical compositions
EP1574516A1 (en) * 2004-03-05 2005-09-14 Sanofi-Aventis Antithrombotic compound
US20060183712A1 (en) * 2005-02-17 2006-08-17 The Texas A&M University System Affinity purified heparin/heparan sulfate for controlling the biological activity of the FGF receptor
US9139876B1 (en) 2007-05-03 2015-09-22 Momenta Pharmacueticals, Inc. Method of analyzing a preparation of a low molecular weight heparin
ES2340902B1 (es) * 2008-07-01 2011-05-03 Laboratorios Farmaceuticos Rovi, S.A. Composicion farmaceutica con glicosaminoglicanos y su uso en tratamiento de ulceras cronicas.
CN101711771B (zh) * 2008-10-07 2015-12-09 上海喜恩医药科技发展有限公司 一种肝素衍生的多糖混合物及其制法和药物组合物
US8435795B2 (en) * 2010-01-19 2013-05-07 Momenta Pharmaceuticals, Inc. Evaluating heparin preparations
CN102399379B (zh) * 2010-09-09 2016-08-31 上海喜恩医药科技发展有限公司 一种肝素衍生的多糖混合物及其制备方法和药物组合物
WO2012072799A1 (en) * 2010-12-02 2012-06-07 Aventis Pharma S.A. New methods for the in vitro measurement of the biological activity of an ultra low molecular weight heparin sample
WO2012115952A1 (en) 2011-02-21 2012-08-30 Momenta Pharmaceuticals, Inc. Evaluating heparin preparations
CN102816255B (zh) * 2011-06-10 2015-11-25 王芃 一种超低分子肝素钠的制备方法
ES2445494B1 (es) 2012-08-02 2015-03-06 Rovi Lab Farmaceut Sa Procedimiento de obtención de heparinas de bajo y muy bajo peso molecular
US20160331775A1 (en) * 2015-05-14 2016-11-17 The Regents Of The University Of Michigan E-selectin inhibition works in combination with low-molecular weight heparin to decrease venous thrombosis and bleeding risk
MA55388A (fr) 2019-04-26 2022-01-26 Farm Rovi Lab Sa Procédé d'obtention d'héparines de faible poids moléculaire par filtration à flux tangentiel
ES2847281A1 (es) * 2020-01-31 2021-08-02 Farm Rovi Lab Sa Heparinas de bajo y muy bajo peso molecular para el tratamiento de trombosis venosa profunda
ES2792298B2 (es) * 2020-04-27 2022-04-20 Farm Rovi Lab Sa Procedimiento para la obtencion de heparinas de bajo peso molecular y heparinas de bajo peso molecular obtenidas por el mismo
CN113384758B (zh) * 2021-06-18 2022-10-04 海思盖德(苏州)生物医学科技有限公司 抗凝血涂层组合物及其制备方法与应用

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2548672A1 (fr) * 1983-07-04 1985-01-11 Pharmuka Lab Oligosaccharides sulfates et leur utilisation comme medicaments
ES2003197A6 (es) * 1987-01-05 1988-10-16 Rovi Lab Farmaceut Sa Procedimiento de despolimerizacion de la heparina para la obtencion de una heparina de bajo peso molecular dotada de actividad antitrombotica
US4981955A (en) * 1988-06-28 1991-01-01 Lopez Lorenzo L Depolymerization method of heparin
GB8826448D0 (en) * 1988-11-11 1988-12-14 Thrombosis Res Inst Improvements in/relating to organic compounds
JP3522775B2 (ja) * 1992-07-03 2004-04-26 生化学工業株式会社 ヘパリン不飽和４糖およびその製造法
US6001820A (en) * 1995-03-31 1999-12-14 Hamilton Civic Hospitals Research Development Inc. Compositions and methods for inhibiting thrombogenesis
KR100512671B1 (ko) * 1996-11-27 2005-09-07 아벤티스 파마슈티칼스 인크. 항 Ｘａ 활성을 지닌 화합물 및 혈소판 응집 길항제 화합물을포함하는 약제학적 조성물
IT1290814B1 (it) * 1997-03-24 1998-12-11 Istituto Scient Di Chimica E B Glicosaminoglicani aventi elevata attivita' antitrombotica
AU7753898A (en) * 1997-06-06 1998-12-21 Hamilton Civic Hospitals Research Development, Inc. Modified low molecular weight heparin that inhibits clot associated coagulation factors

Also Published As

Publication number Publication date
BR9905820A (pt) 2001-03-13
EP1070503A1 (en) 2001-01-24
ES2244165T3 (es) 2005-12-01
US6384021B1 (en) 2002-05-07
ATE309693T1 (de) 2005-07-15
DE69925821T2 (de) 2006-05-18
DE69925821D1 (de) 2005-07-21
EP1070503B1 (en) 2005-06-15
DK1070503T3 (da) 2005-12-05
EP1070503B8 (en) 2005-09-14
ES2161615A1 (es) 2001-12-01
ES2161615B1 (es) 2003-03-16

Similar Documents

Publication Publication Date Title
PT1070503E (pt) Composicoes compreendendo heparina de peso molecular muito reduzido
NO903089D0 (no) Polymere basisblandinger med strukturendret stivelse.
BR0317296A (pt) Método de tratamento de uma formação subterrânea
HK1051867A1 (en) Derivatives of partially desulphated glycosaminoglycans endowed with antiangiogenic activity and devoid of anticoagulating effect
DE69842021D1 (de) Aminozucker, Chondroitin und S-Adenosylmethionin enthaltende Zusammensetzungen
DK0842934T3 (da) 5-HT1F agonister
BR9105924A (pt) Composicao polimerica dissipadora de eletrostatica,artigo polimerico e processo para preparar a dita composicao
DK399588D0 (da) Pentasaccharider
BR9916881A (pt) Métodos para tratamento do câncer ovariano, composições de poli(fosfoéster) e artigos biodegradáveis das mesmas
ATE114695T1 (de) Selbst-löschende polymerische zusammensetzungen.
KR970006422A (ko) 수용성폴리머와 오르가노실리콘 화합물로 구성된 수-재분산성분말을 기재로한 코팅 조성물
TR199901334A2 (xx) Sa� muamelesi i�in maddeler ve bu maddelerin bile�imleri.
BRPI0410133A (pt) artigos moldados ou extrudados compreendendo composições de copolìmero de poliidroxialcanoato com tempos curtos de ciclo de recozimento
CA2055356A1 (en) Thermal stabilizers
FI931740A (fi) Semisyntetiska glukosaminoglykaner innehaollande a-l-galakturonsyra somaer substituerad i 3-staellning med nukleofila radikaler
BR0207646A (pt) Composição estabilizadora para polìmeros halogenados, uso da mesma e polìmeros que compreendem tais composições
BR9900114A (pt) Composições de ciclodextrina.
DE60208211D1 (de) Polycarbonatharzzusammensetzungen und daraus hergestellte artikel
NO996212L (no) Polymerblanding med høy transparens
BR9907384A (pt) Composto de amina impedida, composição de resina, fibra de poliuretano e método de produção e seu uso
BR9003927A (pt) Composicao de resina de poliacetal resistente as condicoes do tempo e artigos moldados,resistentes as condicoes do tempo formados da mesma
PT916670E (pt) Pirrolo-(3,2-b) piridinas e o seu uso como agonistas do 5-ht1f
DE69218199D1 (de) Polyacetal zusammensetzung
BR9909461A (pt) Dibenzonaftironas e o uso das mesmas para colorir ou pigmentar material orgânico de alto peso molecular
ES2101302T3 (es) Composiciones de moldeo reforzadas con propiedades de cristalizacion mejoradas.